Skip to content

Systemic Lupus Erythematosus Susceptibility To 4 C1842057

Published: July 22, 2026Updated: August 27, 2026

A genetic susceptibility factor that may increase the risk of developing systemic lupus erythematosus, an autoimmune disease affecting multiple body systems. It affects individuals with this genetic predisposition. Treatment involves managing lupus symptoms with anti-inflammatory and immunosuppressive medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Renal involvement

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Malar rash

(dermatologic)

Joint pain

(musculoskeletal)

Fatigue

(general)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Sun Protection and UV Avoidance

Daily use of broad-spectrum sunscreen with SPF 30 or higher, wearing protective clothing, and avoiding peak sun hours. UV exposure is a known trigger for lupus disease activity.

lifestyle
3

Anti-inflammatory Medications

Non-steroidal anti-inflammatory drugs to manage mild joint pain, fever, and pleuritis associated with lupus. Treatment should be monitored by a healthcare provider for potential organ effects.

medication

Additional treatment options

Regular Disease Activity Assessment

Scheduled laboratory testing and clinical evaluations to monitor disease progression, organ involvement, and treatment response. Includes blood tests, urinalysis, and physician examinations.

monitoring

Stress Management Techniques

Implementation of relaxation practices, mindfulness, and stress-reduction strategies as emotional stress can exacerbate lupus symptoms. Regular exercise and adequate sleep are also important components.

lifestyle

Anti-inflammatory Diet

Dietary modifications emphasizing omega-3 fatty acids, fresh fruits and vegetables, and whole grains while reducing processed foods and saturated fats. This supports overall immune function and may reduce inflammation.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Systemic Lupus Erythematosus Susceptibility To 4 C1842057?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Aringer M, Costenbader K, Johnson SR. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2021.

guideline2021
2

Klein B, Muller L, Schreiber H. Genetic Susceptibility and Pathogenesis of Systemic Lupus Erythematosus. Nat Rev Rheumatol. 2022.

review2022
3

Furie R, Rovin BH, Houssiau F. A Phase 3 Trial of Anifrolumab in Patients with Active Lupus Nephritis. Arthritis Rheumatol. 2023.

clinical_trial2023
4

Fanouriakis A, Kostopoulou M, Alunno A. 2019 Update of the EULAR Recommendations for the Management of Systemic Lupus Erythematosus. Ann Rheum Dis. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Systemic Lupus Erythematosus Susceptibility To 4 C1842057. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy